A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum
about
Applications of targeted proteomics in systems biology and translational medicineAdvances in targeted proteomics and applications to biomedical researchConjugating a groove-binding motif to an Ir(iii) complex for the enhancement of G-quadruplex probe behaviorSensitive targeted quantification of ERK phosphorylation dynamics and stoichiometry in human cells without affinity enrichment.Targeted proteomics: a bridge between discovery and validation.High expression of AGR2 in lung cancer is predictive of poor survival.The metastasis-inducing protein AGR2 is O-glycosylated upon secretion from mammary epithelial cells.The clinical impact of recent advances in LC-MS for cancer biomarker discovery and verification.Contributions of immunoaffinity chromatography to deep proteome profiling of human biofluidsBiomarker discovery in mass spectrometry-based urinary proteomics.Secretion of protein disulphide isomerase AGR2 confers tumorigenic propertiesBladder cancer cells secrete while normal bladder cells express but do not secrete AGR2.Quantification of angiotensin II-regulated proteins in urine of patients with polycystic and other chronic kidney diseases by selected reaction monitoring.A Timely Shift from Shotgun to Targeted Proteomics and How It Can Be Groundbreaking for Cancer Research.Targeted proteomics of solid cancers: from quantification of known biomarkers towards reading the digital proteome maps.SRM/MRM targeted proteomics as a tool for biomarker validation and absolute quantification in human urine.Absolute quantification of dengue virus serotype 4 chimera vaccine candidate in Vero cell culture by targeted mass spectrometry.Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays.Processing of voided urine for prostate cancer RNA biomarker analysis.Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.Quantification of mutant SPOP proteins in prostate cancer using mass spectrometry-based targeted proteomicsTargeted multiplexed selected reaction monitoring analysis evaluates protein expression changes of molecular risk factors for major psychiatric disorders.Deep-Dive Targeted Quantification for Ultrasensitive Analysis of Proteins in Nondepleted Human Blood Plasma/Serum and Tissues.Quantitative Mass Spectrometry-Based Proteomic Profiling for Precision Medicine in Prostate Cancer.Multiplexed targeted mass spectrometry assays for prostate cancer-associated urinary proteins.Facile carrier-assisted targeted mass spectrometric approach for proteomic analysis of low numbers of mammalian cells
P2860
Q26852271-C16F9FAB-7ED3-4F68-A24E-F823FF241F1DQ28066912-E5C83E97-94D4-4FD9-B718-03CF9B446A89Q33814166-916AA20D-2AE8-4E8E-B095-8D0E75AEDB7CQ35193821-DE9DA5C5-2490-4440-9DD6-057AD16C8F00Q35815142-22042019-0CDC-48F1-875F-9BA4F1AE3021Q36130894-63F40BC9-0A32-4AA7-9B4F-2EF2AC997CE4Q36621607-051ED514-BD9D-4239-8BA6-FA7C97988D71Q36771005-D060028C-B337-40C9-8E03-29821E9754B5Q36889137-BD4E6F5C-BF14-4B6F-A560-84FB2BAC7AC8Q36956324-DF5D2F03-FAB7-4A4C-B31A-735F679114DFQ37083246-C76DABA4-B247-4585-BB61-6195CD38D0B5Q37085875-AC22EB16-B1F3-4C3F-BABC-E743AFF2A782Q37154147-2F0F388F-8DA8-4D22-8523-06064122BA3DQ37651691-45100AC2-DA43-49E6-9511-C224CB950F56Q38604366-99F66CEC-BC24-4404-BE53-4EC49DEE2A86Q38608455-0AB1FC2B-79A3-4D4A-AF3F-D824306DADF0Q38981746-8AD65E81-ED4F-4B25-893F-04F3B8679472Q39637184-ACBCF6E0-4BB7-4F7F-9A01-F573D255FBA4Q40308110-8F7F1B8F-DB8D-4B3A-B747-5CFB25E125E1Q41338779-BDAAD4EF-57F5-4299-ADDC-F39575CD0244Q41414462-4D0EC570-AEB0-46F4-91B9-AE5BAE6FE111Q41651452-C5EF57E1-F885-40D0-8A05-001A90262667Q42279966-00CFF8C3-8425-4A33-965B-E60364B84E0FQ47100267-E7874772-A9CF-4EF4-A213-9249E01FA077Q47136739-6C7FDB40-E311-49F7-BA79-383B9F67E3E5Q57134955-0BD40421-15D9-481A-9248-7B76FA7F1B85
P2860
A highly sensitive targeted mass spectrometric assay for quantification of AGR2 protein in human urine and serum
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A highly sensitive targeted ma ...... otein in human urine and serum
@ast
A highly sensitive targeted ma ...... otein in human urine and serum
@en
A highly sensitive targeted ma ...... otein in human urine and serum
@en-gb
A highly sensitive targeted ma ...... otein in human urine and serum
@nl
type
label
A highly sensitive targeted ma ...... otein in human urine and serum
@ast
A highly sensitive targeted ma ...... otein in human urine and serum
@en
A highly sensitive targeted ma ...... otein in human urine and serum
@en-gb
A highly sensitive targeted ma ...... otein in human urine and serum
@nl
prefLabel
A highly sensitive targeted ma ...... otein in human urine and serum
@ast
A highly sensitive targeted ma ...... otein in human urine and serum
@en
A highly sensitive targeted ma ...... otein in human urine and serum
@en-gb
A highly sensitive targeted ma ...... otein in human urine and serum
@nl
P2093
P2860
P3181
P356
P1476
A highly sensitive targeted ma ...... otein in human urine and serum
@en
P2093
Alvin Y Liu
Carrie D Nicora
Daniel W Chan
David G Camp
Jacob Kagan
Karin D Rodland
Sudhir Srivastava
Sue Ing Quek
P2860
P304
P3181
P356
10.1021/PR400912C
P407
P577
2013-12-03T00:00:00Z